CA2071904A1 - Antibodies to ligand analogues and their utility in ligand-receptor assays - Google Patents
Antibodies to ligand analogues and their utility in ligand-receptor assaysInfo
- Publication number
- CA2071904A1 CA2071904A1 CA002071904A CA2071904A CA2071904A1 CA 2071904 A1 CA2071904 A1 CA 2071904A1 CA 002071904 A CA002071904 A CA 002071904A CA 2071904 A CA2071904 A CA 2071904A CA 2071904 A1 CA2071904 A1 CA 2071904A1
- Authority
- CA
- Canada
- Prior art keywords
- ligand
- antibodies
- analogue
- free
- utility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
- G01N33/541—Double or second antibody, i.e. precipitating antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Means for the detection of free ligand analogue conjugate in fluids from competitive ligand-receptor assay processes. Li-gand analogue antibodies that bind the ligand analogue conjugate with substantially greater affinity than their affinity for target ligand are selected and used in competitive ligand-receptor assay processes to bind the free fraction of the ligand analogue conju-gate. This means permits the detection of the free fraction of ligand analogue conjugate even in the presence of substantially high-er concentrations of free target ligand. For the purposes of the present invention, ligand analogue antibodies are antibodies that exhibit at least 100 X greater affinity for the ligand analogue conjugate compared to their affinity for the target ligand.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US583,046 | 1990-09-14 | ||
US07/583,046 US5143852A (en) | 1990-09-14 | 1990-09-14 | Antibodies to ligand analogues and their utility in ligand-receptor assays |
PCT/US1991/006325 WO1992005283A1 (en) | 1990-09-14 | 1991-09-04 | Antibodies to ligand analogues and their utility in ligand-receptor assays |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2071904A1 true CA2071904A1 (en) | 1992-03-15 |
CA2071904C CA2071904C (en) | 2003-02-18 |
Family
ID=24331471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002071904A Expired - Lifetime CA2071904C (en) | 1990-09-14 | 1991-09-04 | Antibodies to ligand analogues and their utility in ligand-receptor assays |
Country Status (11)
Country | Link |
---|---|
US (1) | US5143852A (en) |
EP (1) | EP0475783B1 (en) |
JP (1) | JPH05501922A (en) |
AT (1) | ATE187250T1 (en) |
AU (1) | AU8536191A (en) |
CA (1) | CA2071904C (en) |
DE (1) | DE69131811T2 (en) |
ES (1) | ES2141086T3 (en) |
IE (1) | IE913243A1 (en) |
PT (1) | PT98951B (en) |
WO (1) | WO1992005283A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5451504A (en) * | 1991-07-29 | 1995-09-19 | Serex, Inc. | Method and device for detecting the presence of analyte in a sample |
US5233042A (en) * | 1991-12-16 | 1993-08-03 | Biosite Diagnostics, Inc. | Cocaine derivatives |
US5283344A (en) * | 1993-03-10 | 1994-02-01 | Abbott Laboratories | Coupling method using selective amination of maleimide |
US6653066B1 (en) | 1994-06-17 | 2003-11-25 | Trinity Biotech | Device and method for detecting polyvalent substances |
DE19504198A1 (en) * | 1995-02-09 | 1996-08-14 | Behringwerke Ag | Competitive immunoassay using complex analyte derivatives |
US5795725A (en) * | 1995-04-18 | 1998-08-18 | Biosite Diagnostics Incorporated | Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays |
US6627404B1 (en) | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
US6991907B1 (en) | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
EP0835446B1 (en) | 1995-06-26 | 2003-04-09 | Perseptive Biosystems, Inc. | High speed, automated, continuous flow, multi-dimensional molecular selection and analysis |
US6156521A (en) * | 1997-12-19 | 2000-12-05 | Biosite Diagnostics, Inc. | Methods for the recovery and measurement of troponin complexes |
US5817770A (en) | 1997-03-21 | 1998-10-06 | Drug Abuse Sciences, Inc. | Cocaethylene immunogens and antibodies |
US6830731B1 (en) * | 1998-01-05 | 2004-12-14 | Biosite, Inc. | Immunoassay fluorometer |
US6392894B1 (en) | 1998-01-05 | 2002-05-21 | Biosite Incorporated | Media carrier for an assay device |
US7297554B2 (en) * | 1998-11-18 | 2007-11-20 | Microdiagnostics, Inc. | Immunoassay system |
EP1184666A3 (en) * | 2000-08-21 | 2002-04-10 | Roche Diagnostics GmbH | Auxiliary haptens and haptenylated agents in displacement immunoassays |
EP1395831A2 (en) * | 2001-04-19 | 2004-03-10 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Method for the relative determination of physicochemical properties |
CN101021526B (en) | 2007-03-16 | 2012-01-25 | 艾博生物医药(杭州)有限公司 | Apparatus and method for visual display of detecting result |
US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
WO2014164594A1 (en) | 2013-03-11 | 2014-10-09 | Meso Scale Technologies, Llc. | Improved methods for conducting multiplexed assays |
GB201403815D0 (en) * | 2014-03-04 | 2014-04-16 | Mologic Ltd | Assay |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654090A (en) * | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
US4203802A (en) * | 1971-05-14 | 1980-05-20 | Syva Company | Inhibitable enzyme amplification assay |
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3884898A (en) * | 1972-08-18 | 1975-05-20 | Syva Co | Normorphine derivatives bonded to proteins |
US3878187A (en) * | 1972-09-11 | 1975-04-15 | Syva Co | Polypeptide derivatives of amphetamine and analogs for immunoassays |
US4108972A (en) * | 1974-03-15 | 1978-08-22 | Dreyer William J | Immunological reagent employing radioactive and other tracers |
US4048298A (en) * | 1975-02-25 | 1977-09-13 | Rohm And Haas Company | Solid phase double-antibody radioimmunoassay procedure |
US4200690A (en) * | 1976-12-16 | 1980-04-29 | Millipore Corporation | Immunoassay with membrane immobilized antibody |
US4233402A (en) * | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
JPS5510590A (en) * | 1978-05-04 | 1980-01-25 | Wellcome Found | Enzyme immunity quantity analysis |
US4246339A (en) * | 1978-11-01 | 1981-01-20 | Millipore Corporation | Test device |
US4281065A (en) * | 1979-01-25 | 1981-07-28 | Syva Company | Phencyclidine conjugates to antigenic proteins and enzymes |
DE2923583A1 (en) * | 1979-06-11 | 1980-12-18 | Max Planck Gesellschaft | METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF BASAL MEMBRANE MATERIAL AND NEW BASAL MEMBRANE FRAGMENTS SUITABLE FOR THIS |
US4391904A (en) * | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4425438A (en) * | 1981-03-13 | 1984-01-10 | Bauman David S | Assay method and device |
US4446232A (en) * | 1981-10-13 | 1984-05-01 | Liotta Lance A | Enzyme immunoassay with two-zoned device having bound antigens |
US4506009A (en) * | 1982-03-30 | 1985-03-19 | University Of California | Heterogeneous immunoassay method |
GB8317124D0 (en) * | 1983-06-23 | 1983-07-27 | Ekins R P | Free ligand assay |
US4552839A (en) * | 1983-08-01 | 1985-11-12 | Syntex (U.S.A.) Inc. | Determination of analytes in particle-containing medium |
GB8331514D0 (en) * | 1983-11-25 | 1984-01-04 | Janssen Pharmaceutica Nv | Visualization method |
US4703017C1 (en) * | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
US4865997A (en) * | 1984-02-23 | 1989-09-12 | Becton Dickinson And Company | Assay for ligands by separating bound and free tracer from sample |
US4632901A (en) * | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
EP0219499A1 (en) * | 1984-07-03 | 1987-04-29 | Baralaba Pty. Ltd. | Fuel injector |
US4745075A (en) * | 1984-09-06 | 1988-05-17 | Burroughs Wellcome Co. | Diagnostic test methods |
US4740468A (en) * | 1985-02-14 | 1988-04-26 | Syntex (U.S.A.) Inc. | Concentrating immunochemical test device and method |
CA1272127A (en) * | 1985-04-04 | 1990-07-31 | Hybritech Incorporated | Solid phase system for use in ligand-receptor assays |
JPS62502495A (en) | 1985-04-10 | 1987-09-24 | イムニコン・コ−ポレ−ション | Direct homogeneity test |
US4803170A (en) | 1985-05-09 | 1989-02-07 | Ultra Diagnostics Corporation | Competitive immunoassay method, device and test kit |
US4670381A (en) * | 1985-07-19 | 1987-06-02 | Eastman Kodak Company | Heterogeneous immunoassay utilizing horizontal separation in an analytical element |
US4806311A (en) * | 1985-08-28 | 1989-02-21 | Miles Inc. | Multizone analytical element having labeled reagent concentration zone |
DE3624464A1 (en) * | 1986-07-19 | 1988-01-28 | Boehringer Mannheim Gmbh | METHOD FOR DETECTING AN ANALYTIC AND MEANS SUITABLE FOR THIS |
US4963468A (en) * | 1986-09-05 | 1990-10-16 | Syntex (U.S.A.) Inc. | Immunoseparating strip |
US4959307A (en) * | 1986-09-05 | 1990-09-25 | Syntex (U.S.A.) Inc. | Immunoseparating strip |
EP0271204A3 (en) * | 1986-11-07 | 1989-10-25 | Syntex (U.S.A.) Inc. | Immunochromatographic method and device |
US5028535A (en) * | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
-
1990
- 1990-09-14 US US07/583,046 patent/US5143852A/en not_active Expired - Lifetime
-
1991
- 1991-09-04 CA CA002071904A patent/CA2071904C/en not_active Expired - Lifetime
- 1991-09-04 AU AU85361/91A patent/AU8536191A/en not_active Abandoned
- 1991-09-04 WO PCT/US1991/006325 patent/WO1992005283A1/en active Application Filing
- 1991-09-04 JP JP3515353A patent/JPH05501922A/en active Pending
- 1991-09-12 PT PT98951A patent/PT98951B/en not_active IP Right Cessation
- 1991-09-13 ES ES91308408T patent/ES2141086T3/en not_active Expired - Lifetime
- 1991-09-13 IE IE324391A patent/IE913243A1/en unknown
- 1991-09-13 DE DE69131811T patent/DE69131811T2/en not_active Expired - Fee Related
- 1991-09-13 EP EP91308408A patent/EP0475783B1/en not_active Expired - Lifetime
- 1991-09-13 AT AT91308408T patent/ATE187250T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE913243A1 (en) | 1992-02-25 |
PT98951B (en) | 1999-02-26 |
EP0475783B1 (en) | 1999-12-01 |
EP0475783A1 (en) | 1992-03-18 |
PT98951A (en) | 1994-01-31 |
ATE187250T1 (en) | 1999-12-15 |
US5143852A (en) | 1992-09-01 |
AU8536191A (en) | 1992-04-15 |
ES2141086T3 (en) | 2000-03-16 |
CA2071904C (en) | 2003-02-18 |
JPH05501922A (en) | 1993-04-08 |
WO1992005283A1 (en) | 1992-04-02 |
DE69131811D1 (en) | 2000-01-05 |
DE69131811T2 (en) | 2000-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2071904A1 (en) | Antibodies to ligand analogues and their utility in ligand-receptor assays | |
EP1376130A3 (en) | Assay device with two opposable members | |
CA2178642A1 (en) | Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies | |
CA2064915A1 (en) | Tumour necrosis factor binding ligands | |
ATE177841T1 (en) | CROSSTALK OR CROSSTALK INHIBITORS AND THEIR USE | |
CA2167275A1 (en) | Lyophilized ligand-receptor complexes for assays and sensors | |
CA2195556A1 (en) | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype | |
EP0375422A3 (en) | Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine | |
TW218037B (en) | ||
CA2032907A1 (en) | Hepatitis c assay | |
CA2177362A1 (en) | Sensor device for sandwich assay | |
CA2184195A1 (en) | Screening method for identifying ligands for target proteins | |
EP0468585A3 (en) | Biologically active reagent, analytical element and methods for use of the reagent | |
ATE120233T1 (en) | MONOCLONAL ANTIBODIES, B-SPECIFIC FOR APOLIPOPROTEIN, PRODUCED BY TWO HYBRIDOMES. | |
CA2008304A1 (en) | Assay for bone alkaline phosphatase | |
CA2045475A1 (en) | Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay | |
WO2003046140A3 (en) | Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample | |
CA2207505A1 (en) | Neurological drug screens | |
CA2095245A1 (en) | Method of assay | |
EP1591790A3 (en) | Method and reagents for determining protein S. | |
CA2058175A1 (en) | Methods for determination of an analyte | |
CA2075695A1 (en) | Monoclonal antibodies to sulfonated polymers | |
DE68919294T2 (en) | Confirmatory evidence of Chlamydia trachomatis. | |
CA2080408A1 (en) | Artificial standard and control sera, processes for the preparation thereof and the use thereof | |
CA2081879A1 (en) | Monoclonal antibodies to polyacrylate polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |